•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Enliven Therapeutics Announces Oral Presentation at the EHA 2026 Congress Featuring Additional Positive Phase 1 Clinical Trial Data for ELVN-001 in CML
Qudian Inc. Announces Name and Ticker Change
Qudian (NYSE:QD) vs. Katapult (NASDAQ:KPLT) Financial Analysis
Qudian Inc. Reports Third Quarter 2025 Unaudited Financial Results
Qudian (NYSE:QD) Stock Price Down 3.1% – Time to Sell?
Qudian Inc. Announces Board Approval of Changes to Company Name and Ticker Symbol, as well as Calling of Extraordinary General Meeting
Qudian: The Path Forward Has Become Clearer
Qudian Inc. Announces Changes to Board of Directors
Qudian Inc. Reports Second Quarter 2025 Unaudited Financial Results
Qudian: Could Go Higher Even If A Temporary Pullback Is Likely Close
Qudian: A Slow-motion Privatization?
Qudian Inc. Reports First Quarter 2025 Unaudited Financial Results
Qudian Files Its Annual Report on Form 20-F
Qudian: 60% Discount To Liquidation Value And More Buybacks
Qudian: Balance Sheet Strength Gives The Income Statement Time To Improve
Qudian Inc. Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results
Qudian Inc. Announces Appointment of Auditor
Qudian Inc. Reports Third Quarter 2024 Unaudited Financial Results
Qudian: Success With Last-Mile Delivery And More Share Repurchases
Qudian Inc. Reports Second Quarter 2024 Unaudited Financial Results